Related Experiment Video

Updated: Aug 20, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity

L Bartalena1, C Marcocci2, M L Tanda3

  • 1Department of Medicine and Surgery, University of Insubria, Via Ravasi, 2, 21100, Varese, Italy. luigi.bartalena@uninsubria.it.

Journal of Endocrinological Investigation
|May 28, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Graves’ orbitopathyHearing lossTeprotumumabThyroid-eye disease

More Related Videos

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)08:14

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

Published on: May 4, 2017

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.